Risk factors and efficacy of different intravitreal treatment options for symptomatic focal vitreomacular traction with or without full-thickness macular hole
International Ophthalmology · 2025
DOI: 10.1007/s10792-025-03591-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Ophthalmology, 2025. Verfasst von D Metzger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Eye Medical Care Center, Landshut, Germany. Hauptthemen laut MEDLINE: Retinal Perforations, Fluorocarbons, Fibrinolysin, Visual Acuity. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität München.
Abstract (Originalsprache)
Purpose
To report the efficacy and risk profile of intravitreal injections of Ocriplasmin (IVO) versus Perfluoropropane (PVL) in patients with symptomatic focal vitreomacular traction (VMTS) with or without full-thickness macular hole (FTMH < 400 μm).
Methods
Nineteen patients with VMTS received 0.3 ml perfluoropropane, and 68 patients received Ocriplasmin. Primary success criteria included resolution of vitreomacular traction (VMT) and closure of FTMH < 400 μm. Microstructural changes were evaluated using SD OCT for macular hole size, macular edema, subretinal fluid, ellipsoid zone (EZ), and external limiting membrane (ELM).
Results
In the PVL group, 78.92% experienced VMT resolution. None of the FTMH < 400 μm closed with PVL, but all were closed with subsequent pars plana vitrectomy (ppV). New FTMH developed in 7.1% and rhegmatogenous retinal detachment in 5.3%. EZ/ELM changes occurred in 31.6%. In the IVO group, 70.6% achieved VMT resolution. Of 22 patients with FTMH, 45.6% had closure after IVO, with 12 out of 25 needing ppV. New FTMH occurred in 6.5% and retinal detachment in 4.4%. EZ/ELM changes were observed in 16.2%.
Conclusion
Both PVL and IVO showed similar VMT resolution rates. PVL was less effective in closing FTMH and had higher side effects compared to IVO. In the presence of retinal pathologies, PVL is preferable to IVO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Eye Medical Care Center, Landshut, Germany.
- Rechts der Isar hospital, Technical University of Munich, Munich, Germany.
- Smile Eyes Airport, Eye Clinic Airport Medical Care Center, Terminalstraße Mitte 18, 85356, Munich, Germany. abdalrhmanassaf@gmail.com.
- Rechts der Isar hospital, Technical University of Munich, Munich, Germany. abdalrhmanassaf@gmail.com.
- Deparment of Ophthalmology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
- University Eye Clinic, Ludwig Maximilians University, Munich, Germany.
Förderung
- Technische Universität München
Zitieren
APA
Metzger, D., Assaf, A., Maier, M. M., Groselli, S., Klaas, J., & Feucht, N. (2025). Risk factors and efficacy of different intravitreal treatment options for symptomatic focal vitreomacular traction with or without full-thickness macular hole. International Ophthalmology. https://doi.org/10.1007/s10792-025-03591-6
Vancouver
Metzger D, Assaf A, Maier MM, Groselli S, Klaas J, Feucht N. Risk factors and efficacy of different intravitreal treatment options for symptomatic focal vitreomacular traction with or without full-thickness macular hole. International Ophthalmology. 2025. doi:10.1007/s10792-025-03591-6
BibTeX
@article{Metzger2025,
author = {Metzger, D and Assaf, A and Maier, M M and Groselli, S and Klaas, J and Feucht, N},
title = {Risk factors and efficacy of different intravitreal treatment options for symptomatic focal vitreomacular traction with or without full-thickness macular hole},
journal = {International Ophthalmology},
year = {2025},
doi = {10.1007/s10792-025-03591-6}
}
EUVIMED